Heterotopic ossification (HO) is a well-known complication of total hip arthroplasty (THA), especially when the direct lateral approach is used. In this study, we examined the effect of the selective COX-2 inhibitor, celecoxib, on the rates of HO after THA. A control group consisting of 108 patients that did not receive celecoxib was compared with a study group consisting of 106 patients that did receive celecoxib. We assessed the presence and grade of HO using the Brooker classification and Harris hip scores were determined pre- and postoperatively to better quantify clinical outcomes. In this retrospective study of prospectively collected data, celecoxib is associated with a significant reduction in the incidence of HO in patients undergoing THA.
Get full access to this article
View all access options for this article.
References
1.
BackDLSmithJDDalzielREYoungDAShimminAIncidence of heterotopic ossification after hip resurfacing.ANZ J Surg2007;77(8):642–7
2.
MacfarlaneRJNgBHGamieZPharmacological treatment of heterotopic ossification following hip and acetabular surgery.Expert Opin Pharmacother2008;9(5):767–86
3.
AhrengartLLindgrenUFunctional significance of heterotopic bone formation after total hip arthroplasty.J Arthroplasty1989;4(2):125–31
4.
DeLeeJFerrariACharnleyJEctopic bone formation following low friction arthroplasty of the hip.Clin Orthop Relat Res1976(121):53–9
5.
EggliSWooARisk factors for heterotopic ossification in total hip arthroplasty.Arch Orthop Trauma Surg2001;121(9):531–5
6.
FreibergAACantorRFreibergRAThe use of aspirin to prevent heterotopic ossification after total hip arthroplasty.A preliminary reportClin Orthop Relat Res1991(267):93–6
7.
Kjaersgaard-AndersenPRitterMAShort-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty.A preliminary reportClin Orthop Relat Res1992(279):157–62
8.
NealBCRodgersAGrayHNo effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: a randomized trial of 2,649 patients.Acta Orthop Scand2000;71(2):129–34
9.
PedersenNWKristensenSSSchmidtSAPedersenPKjaersgaard-AndersenPFactors associated with heterotopic bone formation following total hip replacement.Arch Orthop Trauma Surg1989;108(2):92–5
10.
PavlouGSalhabMMurugesanLRisk factors for heterotopic ossification in primary total hip arthroplasty.Hip Int2012;22(1):50–5
11.
GriffinDBBeauléPEMattaJMSafety and efficacy of the extended iliofemoral approach in the treatment of complex fractures of the acetabulum.J Bone Joint Surg Br2005;87(10):1391–6
12.
BoardTNKarvaABoardREGambhirAKPorterMLThe prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty.J Bone Joint Surg Br2007;89(4):434–40
13.
RomanoCLDuciDRomanoDMazzaMMeaniECelecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.J Arthroplasty2004;19(1):14–8
14.
SaudanMSaudanPPernegerTRiandNKellerAHoffmeyerPCelecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial.J Bone Joint Surg Br2007;89(2):155–9
15.
LeesePTHubbardRCKarimAIsaksonPCYuSSGeisGSEffects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial.J Clin Pharmacol2000;40(2):124–32
16.
BrookerAFBowermanJWRobinsonRARileyLHJrEctopic ossification following total hip replacement. Incidence and a method of classification.J Bone Joint Surg Am1973;5(8):1629–32
17.
KocicMLazovicMMitkovicMDjokicBClinical significance of the heterotopic ossification after total hip arthroplasty.Orthopedics2010;33(1):16
18.
AyersDCEvartsCMParkinsonJRThe prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty.J Bone Joint Surg Am1986;68(9):1423–30
19.
KienapfelHKollerMWustAPrevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication.Arch Orthop Trauma Surg1999;1195-6296–302
20.
KölblOKnellesDBarthelTRauneckerFFlentjeMEulertJPreoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial.Int J Radiat Oncol Biol Phys1998;42(2):397–401
21.
MooreTJFunctional outcome following surgical excision of heterotopic ossification in patients with traumatic brain injury.J Orthop Trauma1993;7(1):11–4
22.
BarthelTBaumannBNothUEulertJProphylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.Acta Orthop Scand2002;73(6):611–4
23.
CellaJPSalvatiEASculcoTPIndomethacin for the prevention of heterotopic ossification following total hip arthroplasty.Effectiveness, contraindications, and adverse effectsJ Arthroplasty1998;3(3):229–34
24.
MattaJMSiebenrockKADoes indomethacin reduce heterotopic bone formation after operations for acetabular fractures?A prospective randomised studyJ Bone Joint Surg Br1997;79(6):959–63
25.
BombardierCLaineLReicinAComparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.VIGOR Study GroupN Engl J Med2000;343(21):1520–8
26.
SilversteinFEFaichGGoldsteinJLGastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial.Celecoxib Long-term Arthritis Safety StudyJAMA2000;284(10):1247–55
27.
JuniPNarteyLReichenbachSSterchiRDieppePAEggerMRisk of cardiovascular events and rofecoxib: cumulative meta-analysis.Lancet2004;364(9450):2021–9
28.
ReisHJKusswetterWSchellingerTThe suppression of heterotopic ossification after total hip arthroplasty.Int Orthop1992;16(2):140–5
29.
RitterMAVaughanRBEctopic ossification after total hip arthroplasty.Predisposing factors, frequency, and effect on resultsJ Bone Joint Surg Am1977;59(3):345–51
